{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:56:26Z","timestamp":1785761786115,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.psychres.2020.112993","type":"journal-article","created":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T17:55:01Z","timestamp":1586714101000},"page":"112993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: A population-based study"],"prefix":"10.1016","volume":"288","author":[{"given":"Babette","family":"Bais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Munk-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Bergink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.112993_bib0001","doi-asserted-by":"crossref","unstructured":"Arch, J.J., 2014. Cognitive behavioral therapy and pharmacotherapy for anxiety: treatment preferences and credibility among pregnant and non-pregnant women. Behav. Res. Ther. 52, 53\u201360.","DOI":"10.1016\/j.brat.2013.11.003"},{"key":"10.1016\/j.psychres.2020.112993_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines. When and what to use","volume":"48","author":"Ashton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2020.112993_bib0003","doi-asserted-by":"crossref","unstructured":"Askaa, B., Jimenez-Solem, E., Enghusen Poulsen, H., Traerup Andersen, J., 2014. Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy. Obstet. Gynecol. Int. 2014, 945621.","DOI":"10.1155\/2014\/945621"},{"key":"10.1016\/j.psychres.2020.112993_bib0004","doi-asserted-by":"crossref","unstructured":"Ban, L., Tata, L.J., West, J., Fiaschi, L., Gibson, J.E., 2012. Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One 7, e43462.","DOI":"10.1371\/journal.pone.0043462"},{"key":"10.1016\/j.psychres.2020.112993_bib0005","doi-asserted-by":"crossref","unstructured":"Bandelow, B., Lichte, T., Rudolf, S., Wiltink, J., Beutel, M.E., 2014. The diagnosis of and treatment recommendations for anxiety disorders. Dtsch. Arztebl. Int. 111, 473\u2013480.","DOI":"10.3238\/arztebl.2014.0473"},{"key":"10.1016\/j.psychres.2020.112993_bib0006","doi-asserted-by":"crossref","unstructured":"Bergman, U., Rosa, F.W., Baum, C., Wiholm, B.E., Faich, G.A., 1992. Effects of exposure to benzodiazepine during fetal life. Lancet 340, 694\u2013696.","DOI":"10.1016\/0140-6736(92)92232-5"},{"key":"10.1016\/j.psychres.2020.112993_bib0007","unstructured":"Berney, P., Halperin, D., Tango, R., Daeniker-Dayer, I., Schulz, P., 2008. A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders. Psychopharmacol. Bull. 41, 39\u201347."},{"key":"10.1016\/j.psychres.2020.112993_bib0008","doi-asserted-by":"crossref","unstructured":"Bjorn, A.M., Norgaard, M., Hundborg, H.H., Nohr, E.A., Ehrenstein, V., 2011. Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin. Epidemiol. 3, 149\u2013156.","DOI":"10.2147\/CLEP.S17747"},{"key":"10.1016\/j.psychres.2020.112993_bib0009","doi-asserted-by":"crossref","unstructured":"Bliddal, M., Broe, A., Pottegard, A., Olsen, J., Langhoff-Roos, J., 2018. The Danish Medical Birth Register. Eur. J. epidemiol. 33, 27\u201336.","DOI":"10.1007\/s10654-018-0356-1"},{"key":"10.1016\/j.psychres.2020.112993_bib0010","unstructured":"Brunton, L.L., Chabner, B.A., Knollmann, B.C., 2011. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th ed. McGraw-Hill Medicat, New York."},{"key":"10.1016\/j.psychres.2020.112993_bib0011","doi-asserted-by":"crossref","unstructured":"D'Hulst, C., Atack, J.R., Kooy, R.F., 2009. The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov. Today 14, 866\u2013875.","DOI":"10.1016\/j.drudis.2009.06.009"},{"key":"10.1016\/j.psychres.2020.112993_bib0012","doi-asserted-by":"crossref","unstructured":"Daw, J.R., Hanley, G.E., Greyson, D.L., Morgan, S.G., 2011. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol. Drug Saf. 20, 895\u2013902.","DOI":"10.1002\/pds.2184"},{"key":"10.1016\/j.psychres.2020.112993_bib0013","doi-asserted-by":"crossref","unstructured":"Daw, J.R., Mintzes, B., Law, M.R., Hanley, G.E., Morgan, S.G., 2012. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin. Ther. 34, 239-249 e232.","DOI":"10.1016\/j.clinthera.2011.11.025"},{"key":"10.1016\/j.psychres.2020.112993_bib0014","unstructured":"Denmark Statistics, 2013. H\u00e5ndbog til data i L\u00e6gemiddelstatistikregisteret [Handbook for data in the Product Statistics Register]."},{"key":"10.1016\/j.psychres.2020.112993_bib0015","doi-asserted-by":"crossref","unstructured":"Donoghue, J., Lader, M., 2010. Usage of benzodiazepines: A review. Int. J. Psychiatry Clin. Pract. 14, 78\u201387.","DOI":"10.3109\/13651500903447810"},{"key":"10.1016\/j.psychres.2020.112993_bib0016","unstructured":"Einarson, A., Selby, P., Koren, G., 2001. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J. Psychiatry Neurosci. 26, 44\u201348."},{"key":"10.1016\/j.psychres.2020.112993_bib0017","doi-asserted-by":"crossref","unstructured":"Enato, E., Moretti, M., Koren, G., 2011. The fetal safety of benzodiazepines: an updated meta-analysis. J. Obstet. Gynaecol. Can. 33, 46\u201348.","DOI":"10.1016\/S1701-2163(16)34772-7"},{"key":"10.1016\/j.psychres.2020.112993_bib0018","doi-asserted-by":"crossref","unstructured":"Freeman, M.P., Goez-Mogollon, L., McInerney, K.A., Davies, A.C., Church, T.R., Sosinsky, A.Z., Noe, O.B., Viguera, A.C., Cohen, L.S., 2018. Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: results from a prospective registry of women with psychiatric disorders. Gen. Hosp. Psychiatry 53, 73\u201379.","DOI":"10.1016\/j.genhosppsych.2018.05.010"},{"key":"10.1016\/j.psychres.2020.112993_bib0019","doi-asserted-by":"crossref","unstructured":"Grote, N.K., Bridge, J.A., Gavin, A.R., Melville, J.L., Iyengar, S., Katon, W.J., 2010. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch. Gen. Psychiatry 67, 1012\u20131024.","DOI":"10.1001\/archgenpsychiatry.2010.111"},{"key":"10.1016\/j.psychres.2020.112993_bib0020","doi-asserted-by":"crossref","unstructured":"Hanley, G.E., Mintzes, B., 2014. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth. 14, 242.","DOI":"10.1186\/1471-2393-14-242"},{"key":"10.1016\/j.psychres.2020.112993_bib0021","doi-asserted-by":"crossref","unstructured":"Hanley, J.A., Negassa, A., Edwardes, M.D., Forrester, J.E., 2003. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am. J. Epidemiol. 157, 364\u2013375.","DOI":"10.1093\/aje\/kwf215"},{"key":"10.1016\/j.psychres.2020.112993_bib0022","doi-asserted-by":"crossref","unstructured":"Hurault-Delarue, C., Damase-Michel, C., Finotto, L., Guitard, C., Vayssiere, C., Montastruc, J.L., Montastruc, F., Lacroix, I., 2016. Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database. Fundam. Clin. Pharmacol. 30, 476\u2013482.","DOI":"10.1111\/fcp.12209"},{"key":"10.1016\/j.psychres.2020.112993_bib0023","doi-asserted-by":"crossref","unstructured":"Ingstrup, K.G., Liu, X., Gasse, C., Debost, J.P., Munk-Olsen, T., 2018. Prescription drug use in pregnancy and variations according to prior psychiatric history. Pharmacoepidemiol. Drug Saf. 27, 105\u2013113.","DOI":"10.1002\/pds.4355"},{"key":"10.1016\/j.psychres.2020.112993_bib0024","doi-asserted-by":"crossref","unstructured":"Jarde, A., Morais, M., Kingston, D., Giallo, R., MacQueen, G.M., Giglia, L., Beyene, J., Wang, Y., McDonald, S.D., 2016. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry, DOI:10.1001\/jamapsychiatry.2016.0934.","DOI":"10.1001\/jamapsychiatry.2016.0934"},{"key":"10.1016\/j.psychres.2020.112993_bib0025","doi-asserted-by":"crossref","unstructured":"Jorgensen, F.S., 1999. Epidemiological studies of obstetric ultrasound examinations in Denmark 1989-1990 versus 1994-1995. Acta obstetricia et gynecologica Scandinavica 78, 305\u2013309.","DOI":"10.1080\/j.1600-0412.1999.780406.x"},{"key":"10.1016\/j.psychres.2020.112993_bib0026","doi-asserted-by":"crossref","unstructured":"Martin, C.E., Mak, C., Miller, C., Welsh, C., Terplan, M., 2015. Trends in drug-exposed deliveries from 2002 to 2009. Addict. Disord. Treat 14, 61\u201369.","DOI":"10.1097\/ADT.0000000000000044"},{"key":"10.1016\/j.psychres.2020.112993_bib0027","doi-asserted-by":"crossref","unstructured":"Mitchell, A.A., Gilboa, S.M., Werler, M.M., Kelley, K.E., Louik, C., Hernandez-Diaz, S., National Birth Defects Prevention, S., 2011. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am. J. Obstet. Gynecol. 205, 51 e51\u201358.","DOI":"10.1016\/j.ajog.2011.02.029"},{"key":"10.1016\/j.psychres.2020.112993_bib0028","doi-asserted-by":"crossref","unstructured":"Mors, O., Perto, G.P., Mortensen, P.B., 2011. The Danish psychiatric central research register. Scand. J. Public Health 39, 54\u201357.","DOI":"10.1177\/1403494810395825"},{"key":"10.1016\/j.psychres.2020.112993_bib0029","unstructured":"Nelson, J., Chouinard, G., 1999. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian society for clinical pharmacology. Can. J. Clin. Pharmacol. 6, 69\u201383."},{"key":"10.1016\/j.psychres.2020.112993_bib0030","doi-asserted-by":"crossref","unstructured":"Offidani, E., Guidi, J., Tomba, E., Fava, G.A., 2013. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom 82, 355\u2013362.","DOI":"10.1159\/000353198"},{"key":"10.1016\/j.psychres.2020.112993_bib0031","doi-asserted-by":"crossref","unstructured":"Ogawa, Y., Takeshima, N., Furukawa, T.A., 2018. Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: a case-control study using a claims database in Japan. Asia Pac. Psychiatry 10, e12309.","DOI":"10.1111\/appy.12309"},{"key":"10.1016\/j.psychres.2020.112993_bib0032","doi-asserted-by":"crossref","unstructured":"Palmsten, K., Hernandez-Diaz, S., Chambers, C.D., Mogun, H., Lai, S., Gilmer, T.P., Huybrechts, K.F., 2015. The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid Program. Obstet. Gynecol. 126, 465\u2013473.","DOI":"10.1097\/AOG.0000000000000982"},{"key":"10.1016\/j.psychres.2020.112993_bib0033","doi-asserted-by":"crossref","unstructured":"Pottegard, A., Schmidt, S.A.J., Wallach-Kildemoes, H., Sorensen, H.T., Hallas, J., Schmidt, M., 2017. Data Resource Profile: The Danish National Prescription Registry. Int. J. Epidemiol. 46, 798-798f.","DOI":"10.1093\/ije\/dyw213"},{"key":"10.1016\/j.psychres.2020.112993_bib0034","doi-asserted-by":"crossref","unstructured":"Radojcic, M.R., El Marroun, H., Miljkovic, B., Stricker, B.H.C., Jaddoe, V.W.V., Verhulst, F.C., White, T., Tiemeier, H., 2017. Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study. Neurotoxicol. Teratol. 61, 58\u201365.","DOI":"10.1016\/j.ntt.2017.02.005"},{"key":"10.1016\/j.psychres.2020.112993_bib0035","doi-asserted-by":"crossref","unstructured":"Reis, M., Kallen, B., 2013. Combined use of selective serotonin reuptake inhibitors and sedatives\/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study. BMJ Open 3.","DOI":"10.1136\/bmjopen-2012-002166"},{"key":"10.1016\/j.psychres.2020.112993_bib0036","doi-asserted-by":"crossref","unstructured":"Riska, B.S., Skurtveit, S., Furu, K., Engeland, A., Handal, M., 2014. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur. J. Clin. Pharmacol. 70, 1367\u20131374.","DOI":"10.1007\/s00228-014-1744-4"},{"key":"10.1016\/j.psychres.2020.112993_bib0037","doi-asserted-by":"crossref","unstructured":"Sheehy, O., Zhao, J.P., Berard, A., 2019. Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry.","DOI":"10.1001\/jamapsychiatry.2019.0963"},{"key":"10.1016\/j.psychres.2020.112993_bib0038","doi-asserted-by":"crossref","unstructured":"Smolina, K., Hanley, G.E., Mintzes, B., Oberlander, T.F., Morgan, S., 2015. Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002-2011: a population-based cohort study. PLoS One 10, e0128312.","DOI":"10.1371\/journal.pone.0128312"},{"key":"10.1016\/j.psychres.2020.112993_bib0039","doi-asserted-by":"crossref","unstructured":"Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J.W., Patel, V., Silove, D., 2014. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013. Int. J. Epidemiol. 43, 476\u2013493.","DOI":"10.1093\/ije\/dyu038"},{"key":"10.1016\/j.psychres.2020.112993_bib0040","doi-asserted-by":"crossref","unstructured":"Yonkers, K.A., Gilstad-Hayden, K., Forray, A., Lipkind, H.S., 2017. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes. JAMA Psychiatry 74, 1145\u20131152.","DOI":"10.1001\/jamapsychiatry.2017.2733"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119315410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119315410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:39:58Z","timestamp":1759037998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119315410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":40,"alternative-id":["S0165178119315410"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.112993","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.112993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112993"}}